oxatomide has been researched along with Lichen Sclerosus et Atrophicus in 1 studies
oxatomide: structure; an anti-allergic & an anti-asthmatic
oxatomide : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one substituted by a 3-[4-(diphenylmethyl)piperazin-1-yl]propyl group at position 1. It is an anti-allergic drug.
Lichen Sclerosus et Atrophicus: A chronic inflammatory mucocutaneous disease usually affecting the female genitalia (VULVAR LICHEN SCLEROSUS) and BALANITIS XEROTICA OBLITERANS in males. It is also called white spot disease and Csillag's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxatomide is a molecule with both antihistamine and inhibiting activities for the inflammatory response, which may have potential use against this disease." | 2.68 | Topical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosus. ( Ferrari, A; Ferrari, D; Gandini, F; Origoni, M; Rossi, M; Sideri, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Origoni, M | 1 |
| Ferrari, D | 1 |
| Rossi, M | 1 |
| Gandini, F | 1 |
| Sideri, M | 1 |
| Ferrari, A | 1 |
1 trial available for oxatomide and Lichen Sclerosus et Atrophicus
| Article | Year |
|---|---|
Topical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosus.
Topics: Administration, Topical; Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 | 1996 |